Summer Program for Academic Research in Cancer (SPARC)

癌症学术研究暑期项目 (SPARC)

基本信息

项目摘要

The objective of the proposed Summer Program for Academic Research in Cancer (SPARC) at the Indiana University Simon Comprehensive Cancer Center (IUSCCC) is to provide cancer research career pathways for undergraduate and medical students. This objective will be achieved by providing mentored, high-quality, cancer- focused research experiences along with didactic and professional development workshops to undergraduate and first year medical students to prepare them for cancer-related fields. Twenty-five trainees (15 undergraduate and 10 first-year medical students) will be recruited every year to spend 10 weeks performing cancer research and attend didactic and professional development workshops, clinical shadowing with physician-scientist mentors in case of medical student trainees, and networking events. SPARC is open to any eligible student across the country with a residential option for some, but we anticipate the majority of undergraduate students to come from major universities in Indiana including Indiana University, University of Indianapolis, Indiana State University, Purdue University, and the University of Notre Dame, whereas medical students are likely to be from IU School of Medicine, the only allopathic medical school in Indiana, and potentially from Marian University College of Osteopathic Medicine. While undergraduate trainees will potentially become graduate students in the new translational cancer biology PhD program, medical trainees can become part of our recently established Scholarly Concentration in Cancer Biology Research and Practice. Sixty five IUSCCC investigators with previous history of productive mentoring of undergraduate and medical students during summers and active extramurally funded research programs will serve as mentors. Project trainees will gain enhanced laboratory and research skills, including appreciation of the cancer research enterprise and patient care, understanding of career opportunities, and a long-term academic relationship with mentors. Didactic lectures include basic cancer biology, immuno-oncology, and precision therapy, and professional workshops include career opportunities, communicating science, manuscript writing, and tumor board to round out the summer experience. An administrative structure consisting of a principal investigator with administrative and mentoring experience, co- investigators with program implementation, mentoring, and program evaluation experience, and a program manager with recruitment and community outreach experience has been established along with program assessment/refinement by internal and external advisors. A virtual summer research experience in cancer, which we designed and implemented in 2020, will be implemented in years where public health emergencies preclude hands-on training. SPARC continues the success of IUSCCC in administering summer research programs for the past 20 years and expands the scope to fulfill the mission of the IUSCCC to educate students from a diverse educational spectrum who will become ambassadors for cancer knowledge and research in their communities and eventually become biomedical professionals who help in reducing cancer burden.
印第安纳州提议的癌症学术研究夏季夏季计划的目标 西蒙大学综合癌症中心(IUSCCC)将为癌症研究职业提供 本科生和医学生。这一目标将通过提供指导,高质量的癌症 - 专注的研究经验以及教学和专业发展研讨会 和第一年的医学生为他们准备与癌症有关的领域做好准备。 25名学员(15名本科生 每年将招募10名一年级医学生),花10周的时间进行癌症研究 并参加教学和专业发展研讨会,与医师科学家一起临床阴影 在医学生学员和网络活动的情况下进行导师。 SPARC向任何合格的学生开放 在全国范围 来自印第安纳大学,印第安纳波利斯大学印第安纳大学的主要大学 大学,普渡大学和圣母大学,而医学生可能来自 IU医学院,印第安纳州唯一的同种疗法医学院,可能来自玛丽安大学 骨病学院。虽然本科学员有可能成为 新的翻译癌症生物学博士学位计划,医疗学员可以成为我们最近成立的一部分 癌症生物学研究和实践中的学术浓度。六十五名IUSCCC调查人员 夏季和现场活动的本科生和医学生的生产力指导历史 资助的研究计划将担任导师。项目学员将获得增强的实验室和研究 技能,包括对癌症研究企业和患者护理的欣赏,了解职业 机会,与导师的长期学术关系。教学讲座包括基本癌症 生物学,免疫肿瘤学和精确疗法以及专业研讨会包括职业机会, 传达科学,手稿写作和肿瘤委员会,以结束夏季的体验。一个 行政结构由具有行政和指导经验的主要研究人员组成,共同 具有计划实施,指导和计划评估经验以及计划的调查人员 拥有招聘和社区外展经验的经理与计划一起建立了 内部和外部顾问的评估/改进。癌症的虚拟夏季研究经验, 我们在2020年设计和实施,将在公共卫生紧急情况排除的几年中实施 动手训练。 SPARC继续IUSCCC在管理夏季研究计划方面的成功 过去20年,扩大了范围,以履行IUSCCC的使命,以教育来自多样化的学生 教育范围将成为其社区癌症知识和研究的大使 并最终成为帮助减轻癌症负担的生物医学专业人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Harikrishna Nakshatri其他文献

Harikrishna Nakshatri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Harikrishna Nakshatri', 18)}}的其他基金

BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10451507
  • 财政年份:
    2020
  • 资助金额:
    $ 29.58万
  • 项目类别:
BLR&D Research Career Scientist Award Application
BLR
  • 批准号:
    10618238
  • 财政年份:
    2020
  • 资助金额:
    $ 29.58万
  • 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
  • 批准号:
    10515659
  • 财政年份:
    2015
  • 资助金额:
    $ 29.58万
  • 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
  • 批准号:
    10296651
  • 财政年份:
    2015
  • 资助金额:
    $ 29.58万
  • 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
  • 批准号:
    10043823
  • 财政年份:
    2015
  • 资助金额:
    $ 29.58万
  • 项目类别:
Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-7
非转化乳腺上皮细胞中的雌激素-雌激素受体轴:MCF-7 以外的研究
  • 批准号:
    9024970
  • 财政年份:
    2015
  • 资助金额:
    $ 29.58万
  • 项目类别:
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
炭疽毒素受体作为乳腺癌干细胞的标记和靶标
  • 批准号:
    8113776
  • 财政年份:
    2011
  • 资助金额:
    $ 29.58万
  • 项目类别:
Persistent microRNA changes in serum of cancer-free breast cancer patients
无癌乳腺癌患者血清中持续的 microRNA 变化
  • 批准号:
    8240038
  • 财政年份:
    2011
  • 资助金额:
    $ 29.58万
  • 项目类别:
Persistent microRNA changes in serum of cancer-free breast cancer patients
无癌乳腺癌患者血清中持续的 microRNA 变化
  • 批准号:
    8104694
  • 财政年份:
    2011
  • 资助金额:
    $ 29.58万
  • 项目类别:
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
炭疽毒素受体作为乳腺癌干细胞的标记和靶标
  • 批准号:
    8244440
  • 财政年份:
    2011
  • 资助金额:
    $ 29.58万
  • 项目类别:

相似国自然基金

类脑计算系统基准测试研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    190 万元
  • 项目类别:
    国际(地区)合作与交流项目
类脑计算系统基准测试研究
  • 批准号:
    62250006
  • 批准年份:
    2022
  • 资助金额:
    190.00 万元
  • 项目类别:
    国际(地区)合作与交流项目
高性能计算程序的基准测试程序自动生成方法
  • 批准号:
    62202441
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
高性能计算程序的基准测试程序自动生成方法
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于工作负载表征的类脑体系结构基准测试模型与自动映射方法研究
  • 批准号:
  • 批准年份:
    2019
  • 资助金额:
    60 万元
  • 项目类别:
    面上项目

相似海外基金

Administrative Core
行政核心
  • 批准号:
    10703402
  • 财政年份:
    2020
  • 资助金额:
    $ 29.58万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10237260
  • 财政年份:
    2020
  • 资助金额:
    $ 29.58万
  • 项目类别:
Administrative/Clinical Trials Core
行政/临床试验核心
  • 批准号:
    7290718
  • 财政年份:
    2007
  • 资助金额:
    $ 29.58万
  • 项目类别:
AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
  • 批准号:
    7689546
  • 财政年份:
    2006
  • 资助金额:
    $ 29.58万
  • 项目类别:
AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
  • 批准号:
    7689549
  • 财政年份:
    2006
  • 资助金额:
    $ 29.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了